Retension Pharmaceuticals. Inc.

This study tested a new drug, SLx-2101, in 38 adults with moderate to severe high blood pressure. Participants took either 5 mg or 10 mg of the drug once a day for 14 days. The goal was to see if it safely lowers blood pressure and heart rate. The trial was a small, early-phase s…

This study tested a new drug, SLx-2101, in 26 adults with moderate to severe high blood pressure. Participants took the drug once daily for up to 14 days to find the best dose and see how it affects blood pressure. The goal was to check safety and how well the drug lowers blood p…